Tapentadol has been recognized as a step 3 analgesic on the world Health Organization (WHO) pain ladder. Tapentadol is employed for the treatment of moderate to severe pain for chronic and acute musculoskeletal pain. Tapentadol is available within the U.S. in extended release formulations as Nucynta ER from Janssen pharmaceuticals. Nucynta contains the (R,R) stereoisomer, that is a weak compound in terms of opioid activity.
Tapentadol is commonly used to ease pain that can not be managed with other types of analgesics. Tapentadol formulation is provided in 100 mg (red/orange), 5} mg (orange) and 50 mg (yellow) tablets to be used once each five hours as required to regulate pain. in addition, tapentadol will be used for dominant the pain of diabetic neuropathy once round the clock analgesic is needed.
Furthermore, tapentadol will be used to treat chronic depression, though it's not approved for this treatment. However, tapentadol is thought to possess adverse aspect effects. Tapentadol might impair cognitive and physical skills and will not be used once operating serious machinery, particularly throughout initial treatment. Dizziness, nausea, constipation and central system (CNS) sedation ar common aspect effects of tapentadol. Tapentadol will increase the danger of seizure and will be administered fastidiously to epileptic patients.
The growth within the analgesic market is predicted to extend the consumption of tapentadol. additionally, rising demand for over the counter painkillers in rising economies of Asia Pacific is predicted to spice up demand for tapentadol. However, government regulations, musculoskeletal of substitutes and adverse effects of tapentadol could hamper the growth of the market.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Application,End User and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Allergan, Plc, Aristo Pharmaceuticals Pvt. Ltd., Cadila Pharmaceuticals Ltd., Depomed, Inc., Grünenthal, IPCA Laboratories Ltd., Janssen Pharmaceutical, Inc., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Lupin Laboratories Ltd., Manus Aktteva Biopharma LLP., NIKSAN PHARMA CHEM, Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Limited, Taj Pharma (India) Ltd., Tirupati Medicare Ltd, and Treatwell Biotech. |
The covid-19 Impact on Tapentadol Market:
Whereas, the chemicals and accouterments sectors were relatively affected during the pandemic. This is primarily due to uncut demand for chemicals for healthcare, life wisdom, and drawing agents. However, other elements of chemical and material sectors such as types of paints, industrial oil, construction materials are facing reduction in demand. Strict lockdown reflected in a nearly 50-60% reduction in force for raw supply and availability, which directly affected the manufacturing process. Further, halt on numerous end-use diligence directly affected the chemical demand each around the world.
Tapentadol market Segment Overview
By Application, Pain Management segment accounted major market share in forecast period, owing to cancer treatment and management.
By End User , Hospital segment accounted major market share in forecast period, owing to increase infrastructure and technology.
Market Analysis, Insights and Forecast – By Application
· Cough Treatment
· Pain Management
Market Analysis, Insights and Forecast – By End User
· Clinic,
· Hospital,
· Pharmacy
Tapentadol Market Regional Overview
Region-wise, in terms of regions ,The U.S is that the largest country market in North America followed by North American country. Ageing population represents the key growth driver for the US market. Growth-wise, Asia-Pacific is projected to be the quickest growing marketplace for tapentadol.
China and Bharat are expected to be the most important customers of tapentadol in Asia Pacific because of growing population and speedy urbanization. Taiwan, Honk Kong, Japan, Republic of peninsula, Malaysia and country are different major customers of tapentadol in Asia Pacific. Increasing shopper awareness, higher treatment and a rise in life expectancy is probably going to propel future growth.
Tapentadol Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Tapentadol Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Tapentadol are highlighted below.
· In 2011, Janssen pharmaceuticals, Inc. declared the U.S. Food and Drug Administration (FDA) has approved NUCYNTA® ER, an oral analgesic taken twice daily, for the management of moderate to severe chronic pain in adults once a continuous, around-the-clock opioid analgesic is required for an extended amount of time.
Tapentadol Market, Key Players -
· Allergan, Plc,
· Aristo Pharmaceuticals Pvt. Ltd.,
· Cadila Pharmaceuticals Ltd.,
· Depomed, Inc.,
· Grünenthal,
· IPCA Laboratories Ltd.,
· Janssen Pharmaceutical, Inc.,
· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.,
· Lupin Laboratories Ltd.,
· Manus Aktteva Biopharma LLP.,
· NIKSAN PHARMA CHEM,
· Ranbaxy Laboratories Ltd.,
· Sun Pharmaceutical Industries Limited,
· Taj Pharma (India) Ltd.,
· Tirupati Medicare Ltd,
· Treatwell Biotech.
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Tapentadol Market during the forecast period?
Q2. Which segment is projected to hold the largest share in the Tapentadol Market?
Q3. What are the driving factors for the Tapentadol Market?
Q4. Which Segments are covered in the Tapentadol Market report?
Q5. Which are the prominent players offering Tapentadol Market?
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Tapentadol Market analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. •Cough Treatment
- 5.2.2. •Pain Management
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Clinic,
- 5.3.2. •Hospital,
- 5.3.3. •Pharmacy
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East, and Africa
6. North America Tapentadol Market Analysis(USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. •Cough Treatment
- 6.2.2. •Pain Management
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Clinic,
- 6.3.2. •Hospital,
- 6.3.3. •Pharmacy
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. UK
- 6.4.2. Germany
- 6.4.3. France
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Rest of Europe
7. Asia Pacific Tapentadol Market Analysis(USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. •Cough Treatment
- 7.2.2. •Pain Management
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Clinic,
- 7.3.2. •Hospital,
- 7.3.3. •Pharmacy
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. China
- 7.4.2. India
- 7.4.3. Japan
- 7.4.4. Australia
- 7.4.5. South East Asia
- 7.4.6. Rest of Asia Pacific
8. Latin America, Middle East, and Africa Tapentadol Market Analysis(USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. •Cough Treatment
- 8.2.2. •Pain Management
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Clinic,
- 8.3.2. •Hospital,
- 8.3.3. •Pharmacy
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. Brazil
- 8.4.2. Saudi Arabia
- 8.4.3. UAE
- 8.4.4. Rest of LAMEA
9. Competitive Analysis
- 9.1. Company Market Share Analysis, 2018
- 9.2. Key Industry Developments
- 9.3. Company Profile
- 9.4. Janssen Pharmaceutical, Inc.,
- 9.4.1. Business Overview
- 9.4.2. Segment 1 & Service Offering
- 9.4.3. Overall Revenue
- 9.4.4. Geographic Presence
- 9.4.5. Recent Development
- 9.5. Allergan, Plc,
- 9.6. Aristo Pharmaceuticals Pvt. Ltd.,
- 9.7. Cadila Pharmaceuticals Ltd.,
- 9.8. Depomed, Inc.,
- 9.9. Grünenthal,
- 9.10. IPCA Laboratories Ltd.,
- 9.11. Johnson & Johnson Pharmaceutical Research & Development, L.L.C.,
- 9.12. Lupin Laboratories Ltd.,
- 9.13. Manus Aktteva Biopharma LLP.,
- 9.14. NIKSAN PHARMA CHEM,
- 9.15. Ranbaxy Laboratories Ltd.,
- 9.16. Sun Pharmaceutical Industries Limited,
- 9.17. Taj Pharma (India) Ltd.,
- 9.18. Tirupati Medicare Ltd,
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
